817 related articles for article (PubMed ID: 19016706)
1. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.
Rodríguez-Martín M; García Bustínduy M; Sáez Rodríguez M; Noda Cabrera A
Br J Dermatol; 2009 Feb; 160(2):409-14. PubMed ID: 19016706
[TBL] [Abstract][Full Text] [Related]
2. Open trial of topical tacalcitol [1 alpha 24(OH)2D3] and solar irradiation for vitiligo vulgaris: upregulation of c-Kit mRNA by cultured melanocytes.
Katayama I; Ashida M; Maeda A; Eishi K; Murota H; Bae SJ
Eur J Dermatol; 2003; 13(4):372-6. PubMed ID: 12948918
[TBL] [Abstract][Full Text] [Related]
3. Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo.
Lu-yan T; Wen-wen F; Lei-hong X; Yi J; Zhi-zhong Z
Photodermatol Photoimmunol Photomed; 2006 Dec; 22(6):310-4. PubMed ID: 17100739
[TBL] [Abstract][Full Text] [Related]
4. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
[TBL] [Abstract][Full Text] [Related]
5. First case report of topical tacalcitol for vitiligo repigmentation.
Amano H; Abe M; Ishikawa O
Pediatr Dermatol; 2008; 25(2):262-4. PubMed ID: 18429797
[TBL] [Abstract][Full Text] [Related]
6. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience.
Lecha M; Mirada A; López S; Artés M;
J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):414-7. PubMed ID: 15987284
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo.
Bakis-Petsoglou S; Le Guay JL; Wittal R
Br J Dermatol; 2009 Oct; 161(4):910-7. PubMed ID: 19523170
[TBL] [Abstract][Full Text] [Related]
8. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety.
Van de Kerkhof PC; Werfel T; Haustein UF; Luger T; Czarnetzki BM; Niemann R; Plänitz-Stenzel V
Br J Dermatol; 1996 Nov; 135(5):758-65. PubMed ID: 8977677
[TBL] [Abstract][Full Text] [Related]
9. Profile of clinical efficacy and safety of topical tacalcitol.
Leone G; Pacifico A
Acta Biomed; 2005 Apr; 76(1):13-9. PubMed ID: 16116820
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: results of a randomized, double-blind, vehicle-controlled study.
Dawid M; Veensalu M; Grassberger M; Wolff K
J Dtsch Dermatol Ges; 2006 Nov; 4(11):942-6. PubMed ID: 17081269
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
[TBL] [Abstract][Full Text] [Related]
12. Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo.
Kumaran MS; Kaur I; Kumar B
J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):269-73. PubMed ID: 16503885
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of pimecrolimus 1% cream combined with microdermabrasion in the treatment of nonsegmental childhood vitiligo: a randomized placebo-controlled study.
Farajzadeh S; Daraei Z; Esfandiarpour I; Hosseini SH
Pediatr Dermatol; 2009; 26(3):286-91. PubMed ID: 19706089
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck.
Sassi F; Cazzaniga S; Tessari G; Chatenoud L; Reseghetti A; Marchesi L; Girolomoni G; Naldi L
Br J Dermatol; 2008 Nov; 159(5):1186-91. PubMed ID: 18717675
[TBL] [Abstract][Full Text] [Related]
15. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.
Radakovic S; Breier-Maly J; Konschitzky R; Kittler H; Sator P; Hoenigsmann H; Tanew A
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):951-3. PubMed ID: 19496898
[TBL] [Abstract][Full Text] [Related]
16. Pimecrolimus cream in repigmentation of vitiligo.
Seirafi H; Farnaghi F; Firooz A; Vasheghani-Farahani A; Alirezaie NS; Dowlati Y
Dermatology; 2007; 214(3):253-9. PubMed ID: 17377388
[TBL] [Abstract][Full Text] [Related]
17. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.
Stinco G; Piccirillo F; Forcione M; Valent F; Patrone P
Eur J Dermatol; 2009; 19(6):588-93. PubMed ID: 19651562
[TBL] [Abstract][Full Text] [Related]
18. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo.
Hartmann A; Lurz C; Hamm H; Bröcker EB; Hofmann UB
Int J Dermatol; 2005 Sep; 44(9):736-42. PubMed ID: 16135141
[TBL] [Abstract][Full Text] [Related]
19. Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo.
Kullavanijaya P; Lim HW
Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):248-51. PubMed ID: 15379875
[TBL] [Abstract][Full Text] [Related]
20. Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo.
Goldinger SM; Dummer R; Schmid P; Burg G; Seifert B; Läuchli S
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):504-8. PubMed ID: 17373978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
